drugset / Trial / NCT05770674
Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES
Unknown
2186 enrolled
Kiyuk Chang
Bucheon St. Mary's Hospital · collabChungbuk National University Hospital · collabDaejeon St. Mary's hospital · collabKorea University Guro Hospital · collabSeoul St. Mary's Hospital · collabSt Vincent's Hospital · collabUijeongbu St. Mary Hospital · collabWonju Severance Christian Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a prospective, open-label, multicenter, randomized clinical trial to evaluate the efficacy of 1 month dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel followed by clopidogrel monotherapy, compared with 12 months DAPT with aspirin plus clopidogrel in patients undergoing percutaneous coronary intervention with Genoss® drug eluting stents.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | — |
| Comparator | Clopidogrel | Small molecule | 75 mg | — |